Impact of cytochrome P450 2D6 polymorphisms on decision-making and clinical outcomes in adjuvant hormonal therapy for breast cancer.

Tan, Ern-Yu; Bharwani, Lavina; Chia, Yee-Hong; Soong, Richie C T; Lee, Sherylyn S Y; Chen, Juliana J C; Chan, Patrick M Y

Tan, Ern-Yu; Bharwani, Lavina; Chia, Yee-Hong; Soong, Richie C T; Lee, Sherylyn S Y; Chen, Juliana J C; Chan, Patrick M Y.

Afiliação

Tan EY; Department of General Surgery, Tan Tock Seng Hospital, Singapore 308433, Singapore.
Bharwani L; Lee Kong Chian School of Medicine, Singapore 308232, Singapore.
Chia YH; Institute of Molecular and Cell Biology, ASTAR, Singapore 138673, Singapore. ern_yu_tan@ttsh.com.sg.
Soong RCT; Department of Medical Oncology, Tan Tock Seng Hospital, Singapore 308433, Singapore.
Lee SSY; Department of Medical Oncology, Tan Tock Seng Hospital, Singapore 308433, Singapore.
Chen JJC; Cancer Science Institute of Singapore, National University of Singapore, Singapore 119077, Singapore.
Chan PMY; Department of General Surgery, Tan Tock Seng Hospital, Singapore 308433, Singapore.

World J Clin Oncol ; 13(8): 712-724, 2022 Aug 24.

Article em En | MEDLINE | ID: mdl-36160461

Palavras-chave

Breast cancer; Functional cytochrome P450 2D6 polymorphisms; Hormonal therapy

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: World J Clin Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Singapura

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google